Adagio Medical Holdings reported cash from operations of -$5.27M and free cash flow of -$5.28M for the quarter ended Jun 2026, down 12.5% year over year. This cash flow statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | -9.56M | -5.91M | -9.57M | -7.42M | -4.69M | -7.89M | -5.33M | -6.39M | -4.61M | -5.87M | -5.67M | |
| Share-based Compensation | 0.11M | 0.74M | 0.11M | 0.01M | 0.01M | 5.70M | 0.23M | 5.70M | 0.89M | 9.45M | 10.47M | |
| Gains from Investment Securities | 0.02M | -0.04M | 0.08M | -0.09M | -4.97M | -0.04M | 0.14M | 0.23M | -0.35M | 0.13M | -0.18M | |
| Asset Writedowns and Impairment | 0.00M | 0.08M | -0.04M | -0.01M | ||||||||
| Cash from Operations | -7.10M | -6.74M | -6.40M | -7.21M | -4.69M | -4.11M | -4.13M | -5.27M | ||||
| Depreciation, Depletion & Amortization | ||||||||||||
| Amortizatization of Intangibles | 0.01M | 0.01M | 0.01M | |||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.13M | 0.33M | 0.32M | 0.27M | 0.27M | 0.24M | 0.21M | 0.20M | ||||
| Change in Working Capital | ||||||||||||
| Change in Receivables | -0.00M | -0.07M | -0.01M | -0.03M | -0.01M | -0.00M | 0.02M | |||||
| Change in Inventory | 3.03M | 0.28M | 0.13M | -0.26M | -0.50M | 0.12M | -0.07M | 0.38M | ||||
| Change in Account Payables | 0.88M | -0.36M | -0.19M | -1.33M | 0.06M | 0.14M | -0.52M | |||||
| Change in Accured Expenses | -0.22M | 0.68M | -0.65M | -0.58M | 0.24M | -1.50M | 0.14M | -0.49M | ||||
| Other Working Capital Changes | -1.33M | -0.09M | 1.26M | -0.06M | 0.07M | 0.02M | -0.37M | |||||
| Investing Activities | ||||||||||||
| Capital Expenditures | 0.02M | 0.16M | 0.58M | 0.34M | 0.01M | -0.49M | 0.00M | 0.01M | ||||
| Cash from Investing Activities | -0.02M | -0.16M | -0.58M | -0.34M | -0.01M | 0.49M | -0.00M | -0.01M | ||||
| Financing Activities | ||||||||||||
| Other financing activities | 0.01M | |||||||||||
| Debt Issuance and Repayment | ||||||||||||
| Long-Term Debt Issuances | 10.00M | 10.00M | 5.50M | |||||||||
| Change in Capital Stock | ||||||||||||
| Net Shares Issued and Repurchased | 0.00M | 0.01M | 5.69M | 5.78M | 3.67M | |||||||
| Misc. | ||||||||||||
| Cash from Financing Activities | 6.58M | 9.57M | 5.07M | |||||||||
| Exchange Rate Effect | -0.07M | 0.03M | 0.04M | -0.08M | -0.10M | -0.06M | -0.07M | 0.10M | ||||
| Change in Cash | -0.60M | 2.70M | -6.89M | -7.62M | -4.76M | 12.43M | -4.20M | -5.17M | ||||
| Free Cash Flow | -7.12M | -6.90M | -6.98M | -7.55M | -4.70M | -3.62M | -4.13M | -5.28M | ||||
| Net Cash Flow | -0.54M | 2.67M | 5.07M | -6.98M | -7.55M | -4.70M | -3.62M | -4.13M | -5.28M |